PCN94 CAPECITABINE + OXALIPLATIN (XELOX) VS. 5-FU/LV + OXALIPLATIN (FOLFOX4) IN THE ADJUVANT TREATMENT OF PATIENTS WITH COLON CANCER (ACC): COMPARISON OF DIRECT MEDICAL AND SOCIETAL (INDIRECT) COSTS
- Resource Type
- Abstract
- Source
- In
Value in Health 2010 13(7):A269-A269 - Subject
Research Poster Abstracts - Language
- ISSN
- 1098-3015